Exploring the epigenetic drug discovery landscape V Prachayasittikul, P Prathipati, R Pratiwi, C Phanus-Umporn, AA Malik, ... Expert opinion on drug discovery 12 (4), 345-362, 2017 | 84 | 2017 |
THPep: A machine learning-based approach for predicting tumor homing peptides W Shoombuatong, N Schaduangrat, R Pratiwi, C Nantasenamat Computational biology and chemistry 80, 441-451, 2019 | 65 | 2019 |
Mechanisms and neuroprotective activities of stigmasterol against oxidative stress-induced neuronal cell death via sirtuin family R Pratiwi, C Nantasenamat, W Ruankham, W Suwanjang, ... Frontiers in Nutrition 8, 184, 2021 | 53 | 2021 |
CryoProtect: a web server for classifying antifreeze proteins from nonantifreeze proteins R Pratiwi, AA Malik, N Schaduangrat, V Prachayasittikul, JES Wikberg, ... Journal of Chemistry 2017, 2017 | 51 | 2017 |
Towards predicting the cytochrome P450 modulation: from QSAR to proteochemometric modeling W Shoombuatong, P Prathipati, V Prachayasittikul, N Schaduangrat, ... Current drug metabolism 18 (6), 540-555, 2017 | 33 | 2017 |
Rational design of novel sirtuin 1 activators via structure-activity insights from application of QSAR modeling R Pratiwi, V Prachayasittikul, S Prachayasittikul, C Nantasenamat EXCLI journal 18, 207, 2019 | 7 | 2019 |
Potensi Astaxantin sebagai Senyawa Antikanker R Pratiwi, L Limantara Indonesian Journal of Cancer 2 (4), 2008 | 3 | 2008 |
Interpretable SMILES-based QSAR model of inhibitory activity of sirtuins 1 and 2. A Worachartcheewan, AP Toropova, AA Toropov, R Pratiwi, ... Combinatorial Chemistry & High Throughput Screening, 2020 | 2 | 2020 |
EFEK ANTIATEROSKLEROSIS ASTAXANTIN R Pratiwi Biomedika 6 (1), 15-17, 2013 | | 2013 |